收费全文 | 11259篇 |
免费 | 472篇 |
国内免费 | 114篇 |
耳鼻咽喉 | 73篇 |
儿科学 | 148篇 |
妇产科学 | 146篇 |
基础医学 | 1477篇 |
口腔科学 | 234篇 |
临床医学 | 578篇 |
内科学 | 3003篇 |
皮肤病学 | 193篇 |
神经病学 | 990篇 |
特种医学 | 531篇 |
外科学 | 2031篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 385篇 |
眼科学 | 123篇 |
药学 | 699篇 |
中国医学 | 35篇 |
肿瘤学 | 1171篇 |
2023年 | 61篇 |
2022年 | 104篇 |
2021年 | 157篇 |
2020年 | 93篇 |
2019年 | 121篇 |
2018年 | 179篇 |
2017年 | 139篇 |
2016年 | 154篇 |
2015年 | 179篇 |
2014年 | 257篇 |
2013年 | 324篇 |
2012年 | 476篇 |
2011年 | 595篇 |
2010年 | 348篇 |
2009年 | 327篇 |
2008年 | 590篇 |
2007年 | 605篇 |
2006年 | 633篇 |
2005年 | 685篇 |
2004年 | 681篇 |
2003年 | 729篇 |
2002年 | 768篇 |
2001年 | 248篇 |
2000年 | 270篇 |
1999年 | 260篇 |
1998年 | 227篇 |
1997年 | 195篇 |
1996年 | 152篇 |
1995年 | 147篇 |
1994年 | 154篇 |
1993年 | 134篇 |
1992年 | 165篇 |
1991年 | 149篇 |
1990年 | 122篇 |
1989年 | 142篇 |
1988年 | 126篇 |
1987年 | 102篇 |
1986年 | 106篇 |
1985年 | 88篇 |
1984年 | 83篇 |
1983年 | 79篇 |
1982年 | 65篇 |
1981年 | 59篇 |
1980年 | 55篇 |
1979年 | 59篇 |
1978年 | 54篇 |
1977年 | 37篇 |
1976年 | 37篇 |
1975年 | 43篇 |
1972年 | 34篇 |
The effect of SA3443 on the induction of natural killer (NK) and cytotoxic T lymphocyte (CTL) activities was investigated. NK activity in BALB/c mice splenic cells was investigated using YAC-1 cells as target cells. SA3443, at a dose range of 30-300 mg/kg/day, augmented NK activity significantly when administered orally once daily for 4 days before the assay. Alloantigen-specific CTL activity in splenic cells from BALB/c mice was detected 9 days after sensitization with C57BL/6 mice splenic cells. SA3443, at a dose of 100 mg/kg/day, augmented CTL activity significantly when administered orally, once daily for 4 days beginning after the sensitization and for 2 days before the assay, while a high dose of SA3443, at 300mg/kg, suppressed CTL activity.
From these results, it is thought that SA3443 may assist in the elimination of hepatitis viruses from the liver in patients with chronic active hepatitis, by the activation of NK and/or CTL activities. 相似文献
Methods: Platelet aggregation was measured using an eight-channel aggregometer, and cytosolic free calcium concentration was measured in Fura-2/AM-loaded platelets using a fluorometer. Inositol 1,4,5-triphosphate (IP3) was measured with use of a commercially available IP3 assay kit. To estimate thromboxane A2 (TXA2) receptor binding affinity and expression, Scatchard analysis was performed using [3H]S145, a specific TXA2 receptor antagonist. TXA2 agonist binding assay was also performed. The membrane-bound guanosine 5'-triphosphatase activity was determined using [[gamma]-32P]guanosine triphosphate by liquid scintillation analyzer.
Results: Ketamine (500 [mu]m) suppressed aggregation induced by adenosine diphosphate (0.5 [mu]m), epinephrine (1 [mu]m), (+)-9,11-epithia-11,12-methano-TXA2 (STA2) (0.5 [mu]m), and thrombin (0.02 U/ml) to 39.1 +/- 30.9, 46.3 +/- 4.3, -2.0 +/- 16.8, and 86.6 +/- 1.4% of zero-control, respectively. Ketamine (250 [mu]m-1 mm) also suppressed thrombin- and STA2-induced cytosolic free calcium concentration increase dose dependently. Although ketamine (2 mm) had no effect on TXA2 receptor expression and its binding affinity, it (1 mm) suppressed intracellular peak IP3 concentrations induced by thrombin and STA2 from 6.60 +/- 1.82 and 4.39 +/- 2.41 to 2.41 +/- 0.98 and 1.90 +/- 0.86 pmol/109 platelets, respectively, and it suppressed guanosine triphosphate hydrolysis induced by thrombin (0.02 units/ml) and STA2 (0.5 [mu]m) to 50.3 +/- 3.2 and 67.5 +/- 5.5%versus zero-control, respectively. 相似文献